Potential of inflammatory protein signatures for enhanced selection of people for lung cancer screening

Randomized trials have demonstrated a substantial reduction in lung cancer (LC) mortality by screening heavy smokers with low-dose computed tomography (LDCT). The aim of this study was to assess if and to what extent blood-based inflammatory protein biomarkers might enhance selection of those at hig...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bhardwaj, Megha (VerfasserIn) , Schöttker, Ben (VerfasserIn) , Holleczek, Bernd (VerfasserIn) , Benner, Axel (VerfasserIn) , Schrotz-King, Petra (VerfasserIn) , Brenner, Hermann (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 26 April 2022
In: Cancers
Year: 2022, Jahrgang: 14, Heft: 9
ISSN:2072-6694
DOI:10.3390/cancers14092146
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers14092146
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/14/9/2146
Volltext
Verfasserangaben:Megha Bhardwaj, Ben Schöttker, Bernd Holleczek, Axel Benner, Petra Schrotz-King and Hermann Brenner

MARC

LEADER 00000caa a2200000 c 4500
001 1807526860
003 DE-627
005 20220820203421.0
007 cr uuu---uuuuu
008 220623s2022 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers14092146  |2 doi 
035 |a (DE-627)1807526860 
035 |a (DE-599)KXP1807526860 
035 |a (OCoLC)1341461570 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bhardwaj, Megha  |d 1985-  |e VerfasserIn  |0 (DE-588)1147332606  |0 (DE-627)1006074554  |0 (DE-576)495748021  |4 aut 
245 1 0 |a Potential of inflammatory protein signatures for enhanced selection of people for lung cancer screening  |c Megha Bhardwaj, Ben Schöttker, Bernd Holleczek, Axel Benner, Petra Schrotz-King and Hermann Brenner 
264 1 |c 26 April 2022 
300 |a 1-12$t12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a This article belongs to the Section Cancer Epidemiology and Prevention 
500 |a Gesehen am 23.06.2022 
520 |a Randomized trials have demonstrated a substantial reduction in lung cancer (LC) mortality by screening heavy smokers with low-dose computed tomography (LDCT). The aim of this study was to assess if and to what extent blood-based inflammatory protein biomarkers might enhance selection of those at highest risk for LC screening. Ever smoking participants were chosen from 9940 participants, aged 50-75 years, who were followed up with respect to LC incidence for 17 years in a prospective population-based cohort study conducted in Saarland, Germany. Using proximity extension assay, 92 inflammation protein biomarkers were measured in baseline plasma samples of ever smoking participants, including 172 incident LC cases and 285 randomly selected participants free of LC. Smoothly clipped absolute deviation (SCAD) penalized regression with 0.632+ bootstrap for correction of overoptimism was applied to derive an inflammation protein biomarker score (INS) and a combined INS-pack-years score in a training set, and algorithms were further evaluated in an independent validation set. Furthermore, the performances of nine LC risk prediction models individually and in combination with inflammatory plasma protein biomarkers for predicting LC incidence were comparatively evaluated. The combined INS-pack-years score predicted LC incidence with area under the curves (AUCs) of 0.811 and 0.782 in the training and the validation sets, respectively. The addition of inflammatory plasma protein biomarkers to established nine LC risk models increased the AUCs up to 0.121 and 0.070 among ever smoking participants from training and validation sets, respectively. Our results suggest that inflammatory protein biomarkers may have potential to improve the selection of people for LC screening and thereby enhance screening efficiency. 
650 4 |a cancer prevention and screening 
650 4 |a LC risk model 
650 4 |a lung cancer 
650 4 |a proteomics 
650 4 |a risk prediction 
650 4 |a risk stratification 
650 4 |a smoking exposure 
700 1 |a Schöttker, Ben  |e VerfasserIn  |0 (DE-588)138862443  |0 (DE-627)703132423  |0 (DE-576)309375657  |4 aut 
700 1 |a Holleczek, Bernd  |d 1973-  |e VerfasserIn  |0 (DE-588)1053591020  |0 (DE-627)790337649  |0 (DE-576)409545155  |4 aut 
700 1 |a Benner, Axel  |d 1959-  |e VerfasserIn  |0 (DE-588)106584686X  |0 (DE-627)81687221X  |0 (DE-576)425536602  |4 aut 
700 1 |a Schrotz-King, Petra  |e VerfasserIn  |0 (DE-588)1078258066  |0 (DE-627)838209327  |0 (DE-576)450367118  |4 aut 
700 1 |a Brenner, Hermann  |e VerfasserIn  |0 (DE-588)1020516445  |0 (DE-627)691247005  |0 (DE-576)360642136  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 14(2022), 9, Artikel-ID 2146  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Potential of inflammatory protein signatures for enhanced selection of people for lung cancer screening 
773 1 8 |g volume:14  |g year:2022  |g number:9  |g elocationid:2146  |g extent:1-12$t12  |a Potential of inflammatory protein signatures for enhanced selection of people for lung cancer screening 
856 4 0 |u https://doi.org/10.3390/cancers14092146  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/14/9/2146  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220623 
993 |a Article 
994 |a 2022 
998 |g 1020516445  |a Brenner, Hermann  |m 1020516445:Brenner, Hermann  |d 850000  |d 851600  |d 50000  |e 850000PB1020516445  |e 851600PB1020516445  |e 50000PB1020516445  |k 0/850000/  |k 1/850000/851600/  |k 0/50000/  |p 6  |y j 
998 |g 1053591020  |a Holleczek, Bernd  |m 1053591020:Holleczek, Bernd  |d 50000  |e 50000PH1053591020  |k 0/50000/  |p 3 
998 |g 138862443  |a Schöttker, Ben  |m 138862443:Schöttker, Ben  |d 850000  |d 851600  |d 50000  |e 850000PS138862443  |e 851600PS138862443  |e 50000PS138862443  |k 0/850000/  |k 1/850000/851600/  |k 0/50000/  |p 2 
999 |a KXP-PPN1807526860  |e 4154678833 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"26 April 2022","dateIssuedKey":"2022"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1807526860"],"doi":["10.3390/cancers14092146"]},"language":["eng"],"physDesc":[{"extent":"1-12$t12 S."}],"person":[{"display":"Bhardwaj, Megha","family":"Bhardwaj","given":"Megha","role":"aut"},{"role":"aut","display":"Schöttker, Ben","family":"Schöttker","given":"Ben"},{"display":"Holleczek, Bernd","family":"Holleczek","given":"Bernd","role":"aut"},{"display":"Benner, Axel","family":"Benner","given":"Axel","role":"aut"},{"role":"aut","given":"Petra","family":"Schrotz-King","display":"Schrotz-King, Petra"},{"display":"Brenner, Hermann","family":"Brenner","given":"Hermann","role":"aut"}],"title":[{"title":"Potential of inflammatory protein signatures for enhanced selection of people for lung cancer screening","title_sort":"Potential of inflammatory protein signatures for enhanced selection of people for lung cancer screening"}],"relHost":[{"pubHistory":["1.2009 -"],"note":["Gesehen am 27.05.2020"],"recId":"614095670","name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"disp":"Potential of inflammatory protein signatures for enhanced selection of people for lung cancer screeningCancers","part":{"year":"2022","extent":"1-12$t12","volume":"14","issue":"9","text":"14(2022), 9, Artikel-ID 2146"},"title":[{"title":"Cancers","title_sort":"Cancers"}],"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["614095670"],"zdb":["2527080-1"],"issn":["2072-6694"]},"language":["eng"],"origin":[{"dateIssuedKey":"2009","publisher":"MDPI","dateIssuedDisp":"2009-","publisherPlace":"Basel"}]}],"name":{"displayForm":["Megha Bhardwaj, Ben Schöttker, Bernd Holleczek, Axel Benner, Petra Schrotz-King and Hermann Brenner"]},"note":["This article belongs to the Section Cancer Epidemiology and Prevention","Gesehen am 23.06.2022"],"recId":"1807526860"} 
SRT |a BHARDWAJMEPOTENTIALO2620